Apronal

Apronal

Clinical data
Routes of administration	Oral
ATC code	N05CM12 (WHO)
Pharmacokinetic data
Excretion	Renal
Identifiers
IUPAC name (±)-N-Carbamoyl-2-propan-2-ylpent-4-enamide
CAS Number	528-92-7 Y
PubChem CID	10715
ChemSpider	10264 Y
UNII	V18J24E25E
KEGG	D03975 Y
ChEMBL	ChEMBL509282 Y
CompTox Dashboard (EPA)	DTXSID00862125
ECHA InfoCard	100.007.677
Chemical and physical data
Formula	C9H16N2O2
Molar mass	184.239 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES O=C(NC(=O)N)C(C(C)C)C\C=C
InChI InChI=1S/C9H16N2O2/c1-4-5-7(6(2)3)8(12)11-9(10)13/h4,6-7H,1,5H2,2-3H3,(H3,10,11,12,13) Y Key:KSUUMAWCGDNLFK-UHFFFAOYSA-N Y
(verify)

Apronal (brand name Sedormid), or apronalide, also known as allylisopropylacetylurea or allylisopropylacetylcarbamide, is a hypnotic/sedative drug of the ureide (acylurea) group synthesized in 1926 by Hoffmann-La Roche that is no longer used except in Japan (See Japanese article). Though it is not a barbiturate, apronalide is similar in structure to the barbiturates (being an open-chain carbamide instead of having a heterocyclic ring). In accordance, it is similar in action to the barbiturates, although considerably milder in comparison (formerly used as a daytime sedative at doses of 1 to 2 grams every 3 to 4 hours). Upon the finding that it caused patients to develop thrombocytopenic purpura, apronalide was withdrawn from clinical use.

See also

• Bromoureide